SPONSOR

University Hospital, Brest

Total Trials

Recruiting

Phases

Phase 3

Conditions studied: Venous Thromboembolic Disease Pulmonary Embolism Venous Thromboembolism Autism Disorder Multiple Disabilities Pain Intellectual Developmental Disorder Brest Cancer Abemaciclib Adjuvant Therapy

University Hospital, Brest is a clinical research sponsor with 16 registered studies on ClinicalTrials.gov, of which 16 are actively recruiting participants. Research covers conditions including Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism, Autism Disorder.

The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Brest

How many clinical trials has University Hospital, Brest sponsored?

ClinicalMetric currently tracks 16 clinical trials sponsored by University Hospital, Brest, of which 16 are actively recruiting participants. These trials cover conditions including Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University Hospital, Brest research focus on?

University Hospital, Brest clinical trials span Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism, Autism Disorder, Multiple Disabilities, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University Hospital, Brest clinical trial?

To participate in a University Hospital, Brest trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Brest trials with current recruitment status updated daily.

University Hospital, Brest

Frequently Asked Questions — University Hospital, Brest

Clinical Trials by University Hospital, Brest

Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)

Impact and Determinants of Success of a Mobile Multidisciplinary Intervention System Specialized in Pain Management for Patients With Moderate to Severe Intellectual Development Disorder, Isolated or Associated With an ASD or Multiple Disability

Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)

Biocollection in MyeloDysplastic Syndrome (P-MDS)

The Impact of Paramedic Training in Simulation on the Experience of Patients Treated for Malignant Brain Tumors in Neurosurgery (IPSIMANON)

Establishment of a Primary Epididymal Cell Model From Epididymal Samples to Study CFTR Gene Regulation

Emotional Intelligence and Chronic Orofacial Pain

Anatomical Assessment of Orbital Contents on Imaging (EACOI)

Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy

Population-based Brest Stroke Registry

Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

Impact of Human Papillomavirus Carriage on IVF/ICSI Results (HPV AMP)

Study of Alloknesia in Atopic Dermatitis

Pathophysiological Study of the Sensitive Scalp

Myeloproliferative Neoplastic Diseases Observatory From Brest